Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) — Net Asset Quality Index
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) has a Net Asset Quality Index of 65.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.80 Billion minus total liabilities of CN¥1.30 Billion yields net assets of CN¥2.50 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Hangzhou Bio-Sincerity Pharma-Tech Co.Lt (301096) total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Net Asset Quality Index Over Time (2019–2025)
This chart shows how Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.'s Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the index stands at 65.8%, representing net assets of CN¥2.50 Billion against total assets of CN¥3.80 Billion CNY. For live market cap and overall valuation, see Hangzhou Bio-Sincerity Pharma-Tech Co.Lt market capitalisation.
Annual Net Asset Quality Index for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (2019–2025)
The table below presents the year-by-year Net Asset Quality Index for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See Hangzhou Bio-Sincerity Pharma-Tech Co.Lt (301096) net assets for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 67.5% | CN¥2.49 Billion | CN¥3.69 Billion | CN¥1.20 Billion | ▼ -1.8 pp |
| 2024 | 69.3% | CN¥2.58 Billion | CN¥3.72 Billion | CN¥1.14 Billion | ▼ -3.8 pp |
| 2023 | 73.2% | CN¥2.68 Billion | CN¥3.67 Billion | CN¥984.97 Million | ▼ -11.6 pp |
| 2022 | 84.7% | CN¥2.48 Billion | CN¥2.93 Billion | CN¥447.45 Million | ▲ +5.5 pp |
| 2021 | 79.2% | CN¥2.32 Billion | CN¥2.92 Billion | CN¥607.10 Million | ▲ +27.7 pp |
| 2020 | 51.5% | CN¥339.54 Million | CN¥658.75 Million | CN¥319.20 Million | ▼ -22.1 pp |
| 2019 | 73.6% | CN¥278.74 Million | CN¥378.63 Million | CN¥99.89 Million | — |